Meiji Holdings Co Ltd
TSE:2269

Watchlist Manager
Meiji Holdings Co Ltd Logo
Meiji Holdings Co Ltd
TSE:2269
Watchlist
Price: 3 233 JPY -0.83% Market Closed
Market Cap: 912.4B JPY

Meiji Holdings Co Ltd
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Meiji Holdings Co Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Meiji Holdings Co Ltd
TSE:2269
Free Cash Flow
¥24.6B
CAGR 3-Years
-13%
CAGR 5-Years
-7%
CAGR 10-Years
0%
Yakult Honsha Co Ltd
TSE:2267
Free Cash Flow
¥31B
CAGR 3-Years
-13%
CAGR 5-Years
-6%
CAGR 10-Years
12%
Ajinomoto Co Inc
TSE:2802
Free Cash Flow
¥99.7B
CAGR 3-Years
14%
CAGR 5-Years
18%
CAGR 10-Years
5%
Kikkoman Corp
TSE:2801
Free Cash Flow
¥33.3B
CAGR 3-Years
7%
CAGR 5-Years
11%
CAGR 10-Years
6%
Nissin Foods Holdings Co Ltd
TSE:2897
Free Cash Flow
-¥5.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Toyo Suisan Kaisha Ltd
TSE:2875
Free Cash Flow
¥46.9B
CAGR 3-Years
32%
CAGR 5-Years
12%
CAGR 10-Years
8%
No Stocks Found

Meiji Holdings Co Ltd
Glance View

Market Cap
875.8B JPY
Industry
Food Products

Meiji Holdings Co., Ltd. has long been a staple in the world of Japanese consumer goods, specifically in the food and pharmaceutical sectors. Established in 2009 as a result of merging Meiji Seika Kaisha, Ltd. and Meiji Dairies Corporation, the company stands as a testament to the power of strategic consolidation, leveraging over a century of expertise from its predecessors. The company's robust product portfolio spans a diverse array of offerings, including dairy products like yogurts and milk, confectioneries like chocolate and candy, as well as nutrition bars and supplements. This triumvirate of product lines allows Meiji Holdings to position itself in both the everyday consumer market and in specialized health-centric industries, exploiting economies of scale and extensive distribution networks that reach far beyond the Japanese archipelago. In the pharmaceutical arena, Meiji Holdings operates under its subsidiary, Meiji Seika Pharma, focusing predominantly on antibacterial drugs, central nervous system treatments, and veterinary products. By integrating research and development with a comprehensive marketing strategy, the company capitalizes on global health trends and regional disease challenges, expanding in markets that emphasize health and dietary improvements. Financially, Meiji Holdings generates revenue by producing goods that tap into both traditional consumer desires and modern nutritional trends. It makes money by introducing high-margin pharmaceutical innovations alongside its well-established consumer brands, thus benefiting from both everyday sales and solutions aimed at pressing global health needs. Together, these strategic components make Meiji Holdings an agile player in a competitive global market, combining heritage with innovation.

Meiji Holdings Co Ltd Intrinsic Value
HIDDEN
Show

See Also

What is Meiji Holdings Co Ltd's Free Cash Flow?
Free Cash Flow
24.6B JPY

Based on the financial report for Jun 30, 2025, Meiji Holdings Co Ltd's Free Cash Flow amounts to 24.6B JPY.

What is Meiji Holdings Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
0%

Over the last year, the Free Cash Flow growth was -21%. The average annual Free Cash Flow growth rates for Meiji Holdings Co Ltd have been -13% over the past three years , -7% over the past five years .

Back to Top